90 related articles for article (PubMed ID: 1003401)
1. In vitro behavior of Corynebacterium parvum-activated cytotoxic macrophages.
Ghaffar A; Cullen RT
J Reticuloendothel Soc; 1976 Nov; 20(5):349-57. PubMed ID: 1003401
[No Abstract] [Full Text] [Related]
2. Interaction of tumor cells and activated macrophages in vitro: modulation by Corynebacterium parvum and gold salt.
Ghaffar A; McBride WH; Cullen RT
J Reticuloendothel Soc; 1976 Oct; 20(4):283-9. PubMed ID: 825644
[No Abstract] [Full Text] [Related]
3. In vitro and in vivo cytotoxicity of adriamycin and daunomycin for murine macrophages.
Mantovani A
Cancer Res; 1977 Mar; 37(3):815-20. PubMed ID: 837378
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms underlying the induction of cytotoxic macrophages by Corynebacterium parvum: in vitro induction of cytotoxicity in normal macrophages by immune lymphocytes.
Cullen RT; Ghaffar A
J Reticuloendothel Soc; 1978 Oct; 24(4):339-49. PubMed ID: 81874
[No Abstract] [Full Text] [Related]
5. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice.
Wolmark N; Levine M; Fisher B
J Reticuloendothel Soc; 1974 Oct; 16(4):252-7. PubMed ID: 4455907
[No Abstract] [Full Text] [Related]
6. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
Wolmark N; Fisher B
Cancer Res; 1974 Nov; 34(11):2869-72. PubMed ID: 4419513
[No Abstract] [Full Text] [Related]
7. Induction of murine lymphokine-activated killer-like cells by Corynebacterium parvum (C. parvum) in vitro: lysis of tumor cells and macrophages by C. parvum-induced killer cells.
Chen MF; Suzuki H; Yano S
Anticancer Res; 1992; 12(2):451-6. PubMed ID: 1580562
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of macrophage activation by corynebacterium parvum. II. In vivo experiments.
Bomford R; Christie GH
Cell Immunol; 1975 May; 17(1):150-5. PubMed ID: 1079165
[No Abstract] [Full Text] [Related]
9. [Mechanism of the antitumor immunity potentiated by anaerobic Corynebacterium parvum].
Miyata H
Fukuoka Igaku Zasshi; 1983 Jul; 74(7):451-69. PubMed ID: 6662469
[No Abstract] [Full Text] [Related]
10. The role of macrophages in the cytotoxic killing of tumour cells in vitro. I. Primary immunization of lymphocytes in vitro for target cell killing and the mechanism of lymphocyte-macrophage cooperation.
Zembala M; Ptak W; Hanczakowska M
Immunology; 1973 Oct; 25(4):631-44. PubMed ID: 4356674
[TBL] [Abstract][Full Text] [Related]
11. Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes.
Warr GW; James K
Immunology; 1975 Mar; 28(3):431-42. PubMed ID: 1092609
[TBL] [Abstract][Full Text] [Related]
12. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
Fisher B; Wolmark N; Coyle J
J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
[No Abstract] [Full Text] [Related]
13. Effects of Corynebacterium parvum alone and in combination with adriamycin in experimental tumor systems.
Houchens DP; Johnson RK; Ovejera A; Gaston MR; Goldin A
Cancer Treat Rep; 1976 Jul; 60(7):823-8. PubMed ID: 1009517
[TBL] [Abstract][Full Text] [Related]
14. Biological effects of Corynebacterium parvum. 3. Amplification of resistance and impairment of active immunity to murine tumours.
Smith SE; Scott MT
Br J Cancer; 1972 Oct; 26(5):361-7. PubMed ID: 4343677
[TBL] [Abstract][Full Text] [Related]
15. Restoration of prostaglandin E2-producing splenic macrophages in 89Sr-treated mice with bone marrow from Corynebacterium parvum primed donors.
Shibata Y
Reg Immunol; 1989; 2(3):169-75. PubMed ID: 2641504
[TBL] [Abstract][Full Text] [Related]
16. The interplay of lymphoid cells and macrophages in tumour immunity.
Alexander P; Evans R; Grant CK
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):645-58. PubMed ID: 5050874
[No Abstract] [Full Text] [Related]
17. In vivo activity of cytotoxic lymphocytes.
Cerottini JC; Freedman LR; Brunner KT
Transplant Proc; 1972 Sep; 4(3):299-301. PubMed ID: 4404149
[No Abstract] [Full Text] [Related]
18. The accumulated effects of repeated systemic or local injections of low doses of Corynebacterium parvum in mice.
Scott MT; Warner SL
Cancer Res; 1976 Apr; 36(4):1335-8. PubMed ID: 1083289
[TBL] [Abstract][Full Text] [Related]
19. Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.
Scott MT
J Natl Cancer Inst; 1974 Sep; 53(3):855-60. PubMed ID: 4213015
[No Abstract] [Full Text] [Related]
20. Modifications in the handling in vitro of 125I-labelled keyhole limpet haemocyanin by peritoneal macrophages from mice pretreated with the adjuvant Corynebacterium parvum.
Wiener E; Bandieri A
Immunology; 1975 Aug; 29(2):265-74. PubMed ID: 1158386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
